Journal article
Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies
The researchers conducted a follow-on study to a phase I randomized, controlled trial conducted in Cuba, 2012, to assess the persistence of poliovirus antibodies at 21–22 months following booster dose of Sabin-IPV compared to Salk-IPV in adults who had received multiple doses of oral poliovirus vaccine (OPV) during childhood. The study concludes that the decay of poliovirus antibodies over a 21–22-month period was similar regardless of the type of booster vaccine used, suggesting the scientific data of Salk IPV long-term persistence and decay may be broadly applicable to Sabin IPV.
Authors
Languages
- English
Publication year
2015
Journal
Trials in Vaccinology
Volume
4
Type
Categories
Diseases
Countries
Tags
WHO Regions
